Skip to main content

Table 1 Stakeholders contributing to each phase

From: Target Product Profiles for medical tests: a systematic review of current methods

Stakeholder groups contributing to each phaseaScopingDraftingConsensus-building
n (%)n (%)n (%)
Researchers14 (32)15 (34)14 (32)
Industry representatives11 (25)11 (25)14 (32)
International public organisations9 (20)12 (27)12 (27)
Clinicians7 (16)8 (18)8 (18)
Representatives of countries and national disease programs5 (11)4 (9)8 (18)
Policy makers4 (9)5 (11)4 (9)
Laboratory experts3 (7)5 (11)3 (7)
Technical/funding agencies2 (5)3 (7)4 (9)
Microbiologists2 (5)4 (9)2 (5)
Implementers2 (5)2 (5)5 (11)
Patient advocates2 (5)1 (2)3 (7)
Non-profit sector1 (2)2 (5)4 (9)
Modellers1 (2)1 (2)1 (2)
Health economists0 (0)2 (5)2 (5)
Donors2 (5)3 (7)1 (2)
Market experts2(5)1 (2)1 (2)
Program manager1 (2)2 (5)2 (5)
Scientific associations1 (2)3 (7)2 (5)
Strategists1 (2)1 (2)0 (0)
Expert (unspecific)1 (2)3 (7)3 (7)
Others2 (5)2 (5)1 (2)
  1. The percentages in relation to stakeholder groups do not add up to 100% because more than one stakeholder group usually contributes to the development of a TPP
  2. aPercentages are calculated in relation to the total number of included TPPs (n = 44)